Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Cantrixil Phase I Study Progresses To Next Stage 2018-10-10 15:15
Jinxin Fertility Completed A New Round of Financing Led by Warburg Pincus and CNCB (Hong Kong) Investment Limited 2018-10-10 11:36
Merck Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Care 2018-10-09 16:23
Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study 2018-10-08 21:00
Hamad Bin Khalifa University's Qatar Biomedical Research Institute Forms New Partnership With Harvard Stem Cell Institute 2018-10-08 20:53
Jennewein Biotechnologie GmbH Acquires Arthus Mineralsprings Bad Honningen to Build a New Integrated Fermentation and Recovery Plant for Human Milk Oligosaccharides 2018-10-08 20:00
Kinetic Step Launch First Biomechanical Exoskeleton on Indiegogo Crowdfunding Platform 2018-10-08 08:00
miR Scientific Presents at 2018 World Urological Oncology Federation Conference 2018-10-04 20:01
Merck Opens M Lab(TM) Collaboration Center in Sao Paulo, Brazil 2018-10-04 20:00
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI 2018-10-04 15:43
Accera closes new investment led by Asia's leading agribusiness group, Wilmar, and rebrands as Cerecin 2018-10-04 15:00
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188 2018-09-30 11:00
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody Sintilimab as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer 2018-09-30 11:00
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody Sintilimab as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer 2018-09-30 11:00
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188 2018-09-30 11:00
TransThera Biosciences Granted IND Approval from FDA to Soon Start Clinical Trials Targeting TNBC 2018-09-28 20:00
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration 2018-09-28 20:00
Medix survey uncovers Hong Kong's fear and confusion around cancer 2018-09-27 18:33
ACT Genomics completed investment on route to become the leading DNA sequencing-based cancer solution provider in Asia 2018-09-26 12:07
Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry 2018-09-25 22:05
1 319 320 321 322 323 440